| Primary |
| Drug Use For Unknown Indication |
43.2% |
| Hypertension |
13.2% |
| Product Used For Unknown Indication |
10.0% |
| Atrial Fibrillation |
5.8% |
| Tachycardia |
5.8% |
| Accidental Exposure |
2.6% |
| Asthma |
2.1% |
| Cardiac Disorder |
2.1% |
| Diuretic Therapy |
2.1% |
| Non-obstructive Cardiomyopathy |
2.1% |
| Arrhythmia |
1.6% |
| Cardiac Failure |
1.6% |
| Suicide Attempt |
1.6% |
| Acute Pulmonary Oedema |
1.1% |
| Diabetes Mellitus |
1.1% |
| Heart Rate Irregular |
1.1% |
| Hypercholesterolaemia |
1.1% |
| Neuralgia |
1.1% |
| Arthropathy |
0.5% |
| Atrial Flutter |
0.5% |
|
| Vomiting |
15.6% |
| Therapeutic Agent Toxicity |
8.9% |
| Renal Failure |
6.7% |
| Suicide Attempt |
6.7% |
| Drug Interaction |
4.4% |
| Dyspnoea |
4.4% |
| Hypertensive Crisis |
4.4% |
| Oedema |
4.4% |
| Orthostatic Hypotension |
4.4% |
| Respiratory Distress |
4.4% |
| Shock |
4.4% |
| Staphylococcal Infection |
4.4% |
| Thrombosis |
4.4% |
| Ureaplasma Infection |
4.4% |
| Ventricular Fibrillation |
4.4% |
| Vision Blurred |
4.4% |
| Accidental Drug Intake By Child |
2.2% |
| Atrioventricular Block |
2.2% |
| Cytolytic Hepatitis |
2.2% |
| Drug Toxicity |
2.2% |
|
| Secondary |
| Drug Use For Unknown Indication |
16.9% |
| Product Used For Unknown Indication |
12.2% |
| Hypertension |
10.2% |
| Chronic Obstructive Pulmonary Disease |
8.9% |
| Epilepsy |
5.8% |
| Supraventricular Tachycardia |
5.6% |
| Dermatitis |
5.1% |
| Thrombosis Prophylaxis |
5.0% |
| Tachycardia Paroxysmal |
3.8% |
| Grand Mal Convulsion |
3.7% |
| Rash |
3.2% |
| Drug Exposure During Pregnancy |
2.8% |
| Atrial Fibrillation |
2.6% |
| Essential Hypertension |
2.5% |
| Type 2 Diabetes Mellitus |
2.2% |
| Nausea |
2.1% |
| Conjunctivitis |
1.8% |
| Pruritus |
1.8% |
| Sleep Disorder |
1.8% |
| Vomiting |
1.8% |
|
| Toxic Epidermal Necrolysis |
17.5% |
| Vomiting |
9.1% |
| Thrombocytopenia |
7.1% |
| Ventricular Fibrillation |
6.5% |
| Oedema |
5.2% |
| Syncope |
5.2% |
| Drug Interaction |
4.5% |
| Haemolytic Anaemia |
4.5% |
| Hypotension |
4.5% |
| Renal Failure |
4.5% |
| Interstitial Lung Disease |
3.9% |
| Somnolence |
3.9% |
| Cytolytic Hepatitis |
3.2% |
| Malaise |
3.2% |
| Renal Failure Acute |
3.2% |
| Tricuspid Valve Disease |
3.2% |
| Hepatitis |
2.6% |
| Hyperkalaemia |
2.6% |
| Hypokalaemia |
2.6% |
| Iron Deficiency Anaemia |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.6% |
| Product Used For Unknown Indication |
21.9% |
| Hypertension |
12.5% |
| Atrial Fibrillation |
5.1% |
| Unevaluable Event |
4.0% |
| Rheumatoid Arthritis |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.2% |
| Osteoporosis |
3.2% |
| Prophylaxis |
2.7% |
| Type 2 Diabetes Mellitus |
2.6% |
| Pain |
2.6% |
| Asthma |
2.6% |
| Non-small Cell Lung Cancer |
2.5% |
| Depression |
2.0% |
| Diabetes Mellitus |
2.0% |
| Gastric Cancer |
1.4% |
| Chronic Lymphocytic Leukaemia |
1.4% |
| Hypercholesterolaemia |
1.3% |
| Intentional Overdose |
1.3% |
| Cardiac Failure |
1.2% |
|
| Vomiting |
14.1% |
| Renal Failure Acute |
10.8% |
| Thrombocytopenia |
10.5% |
| Respiratory Failure |
5.9% |
| Pyrexia |
4.9% |
| Weight Decreased |
4.9% |
| Renal Failure |
4.6% |
| Dyspnoea |
4.2% |
| Pulmonary Embolism |
3.9% |
| Thrombosis |
3.9% |
| Toxic Epidermal Necrolysis |
3.9% |
| Death |
3.6% |
| Tachycardia |
3.6% |
| Muscle Haemorrhage |
3.3% |
| Sepsis |
3.3% |
| International Normalised Ratio Increased |
2.9% |
| Pain |
2.9% |
| Somnolence |
2.9% |
| Tremor |
2.9% |
| Urinary Tract Infection |
2.9% |
|
| Interacting |
| Product Used For Unknown Indication |
23.3% |
| Drug Use For Unknown Indication |
14.7% |
| Atrial Fibrillation |
11.0% |
| Hypertension |
9.2% |
| Atrial Flutter |
7.4% |
| Bronchial Carcinoma |
4.9% |
| Myocardial Infarction |
4.9% |
| Alcoholism |
3.7% |
| Agitation |
2.5% |
| Cardiac Failure |
2.5% |
| Pneumonia Bacterial |
2.5% |
| Restlessness |
2.5% |
| Bronchitis |
1.8% |
| Chronic Obstructive Pulmonary Disease |
1.8% |
| Asthma |
1.2% |
| Hypothyroidism |
1.2% |
| Pancreatic Insufficiency |
1.2% |
| Prostatomegaly |
1.2% |
| Rheumatoid Arthritis |
1.2% |
| Schizoaffective Disorder |
1.2% |
|
| Drug Interaction |
22.5% |
| Sepsis |
10.0% |
| Hyperkalaemia |
7.5% |
| Malaise |
7.5% |
| Hypotension |
5.0% |
| Respiratory Failure |
5.0% |
| Therapeutic Response Unexpected |
5.0% |
| Thoracic Vertebral Fracture |
5.0% |
| White Blood Cells Urine Positive |
5.0% |
| Atrioventricular Block |
2.5% |
| Cardiogenic Shock |
2.5% |
| Death |
2.5% |
| Drug Therapeutic Incompatibility |
2.5% |
| Hyperglycaemia |
2.5% |
| Hyperthermia |
2.5% |
| Lung Infiltration |
2.5% |
| Orthostatic Hypotension |
2.5% |
| Pallor |
2.5% |
| Renal Failure Acute |
2.5% |
| Shock |
2.5% |
|
